Jean‐Jacques Tudesq

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi et al. · Nature Medicine · 2022 · 343 citations · Full text

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 293 citations · Full text

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe et al. · Clinical Microbiology and Infection · 2021 · 219 citations · Full text

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy et al. · Blood · 2022 · 131 citations · Full text

Aggressive B-cell Lymphoma, Immunology, Pathology +18

Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study*

Virginie Lemiale, Stéphanie Pons, Adrien Mirouse et al. · Critical Care Medicine · 2020 · 74 citations